Neuronetics Stock Z Score

STIM Stock

USD 4.44 0.03 0.67%

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out Neuronetics Piotroski F Score and Neuronetics Valuation analysis.

To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.

Build AI portfolio with Neuronetics Stock

At this time, Neuronetics' Net Working Capital is very stable compared to the past year. As of the 30th of July 2025, Capital Lease Obligations is likely to grow to about 28.9 M, while Net Invested Capital is likely to drop about 64.3 M. As of the 30th of July 2025, Non Operating Income Net Other is likely to grow to about 2.7 M, though Net Interest Income is likely to grow to (6.9 M).

Neuronetics Company Z Score Analysis

Neuronetics' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

Z Score

Sum Of

5 Factors

More About Z Score | All Equity Analysis

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

Neuronetics Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Neuronetics is extremely important. It helps to project a fair market value of Neuronetics Stock properly, considering its historical fundamentals such as Z Score. Since Neuronetics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Neuronetics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Neuronetics' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Long Term Debt Total	Capital Surpluse	Total Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment	Net Invested Capital	Net Working Capital	Intangible Assets	Deferred Long Term Liab	Capital Stock	Short Term Investments	Long Term Investments
Total Assets		0.96	0.97	0.51	-0.15	-0.83	0.7	0.76	0.71	0.6	0.97	-0.9	0.48	0.91	0.0	0.85	0.52	0.97	0.78	0.55	0.15	0.67	0.16	-0.58
Total Stockholder Equity	0.96		0.99	0.61	-0.27	-0.77	0.61	0.65	0.61	0.62	0.95	-0.98	0.38	0.95	-0.06	0.78	0.5	1.0	0.84	0.44	0.16	0.49	0.27	-0.44
Net Tangible Assets	0.97	0.99		0.54	-0.18	-0.82	0.68	0.7	0.69	0.63	0.96	-0.97	0.4	0.93	-0.07	0.84	0.48	1.0	0.8	0.52	0.11	0.56	0.19	-0.51
Current Deferred Revenue	0.51	0.61	0.54		-0.78	-0.1	-0.04	0.12	-0.12	0.51	0.46	-0.64	0.45	0.75	0.34	0.1	0.47	0.58	0.81	-0.27	0.57	-0.24	0.66	0.24
Net Debt	-0.15	-0.27	-0.18	-0.78		-0.37	0.52	0.25	0.55	-0.05	-0.15	0.34	0.06	-0.44	-0.17	0.36	-0.25	-0.24	-0.64	0.69	-0.56	0.52	-0.67	-0.53
Retained Earnings	-0.83	-0.77	-0.82	-0.1	-0.37		-0.87	-0.82	-0.96	-0.53	-0.83	0.69	-0.47	-0.65	0.1	-0.97	-0.32	-0.79	-0.42	-0.84	0.2	-0.81	0.12	0.84
Accounts Payable	0.7	0.61	0.68	-0.04	0.52	-0.87		0.72	0.91	0.53	0.63	-0.53	0.46	0.47	-0.05	0.94	0.32	0.63	0.22	0.95	-0.17	0.8	-0.42	-0.73
Long Term Debt	0.76	0.65	0.7	0.12	0.25	-0.82	0.72		0.78	0.62	0.77	-0.56	0.57	0.57	-0.08	0.77	0.14	0.7	0.43	0.62	-0.16	0.75	-0.08	-0.59
Net Receivables	0.71	0.61	0.69	-0.12	0.55	-0.96	0.91	0.78		0.44	0.69	-0.53	0.42	0.49	-0.08	0.95	0.2	0.65	0.23	0.92	-0.37	0.85	-0.36	-0.91
Long Term Debt Total	0.6	0.62	0.63	0.51	-0.05	-0.53	0.53	0.62	0.44		0.58	-0.61	0.77	0.59	0.34	0.55	-0.08	0.63	0.47	0.37	-0.12	0.31	0.15	-0.19
Capital Surpluse	0.97	0.95	0.96	0.46	-0.15	-0.83	0.63	0.77	0.69	0.58		-0.91	0.42	0.87	-0.08	0.81	0.45	0.97	0.73	0.49	0.08	0.67	0.24	-0.55
Total Liab	-0.9	-0.98	-0.97	-0.64	0.34	0.69	-0.53	-0.56	-0.53	-0.61	-0.91		-0.31	-0.93	0.1	-0.71	-0.46	-0.97	-0.84	-0.34	-0.16	-0.37	-0.33	0.34
Short Long Term Debt	0.48	0.38	0.4	0.45	0.06	-0.47	0.46	0.57	0.42	0.77	0.42	-0.31		0.44	0.7	0.44	0.12	0.42	0.27	0.34	-0.03	0.33	0.02	-0.31
Total Current Assets	0.91	0.95	0.93	0.75	-0.44	-0.65	0.47	0.57	0.49	0.59	0.87	-0.93	0.44		0.1	0.65	0.52	0.94	0.94	0.29	0.26	0.32	0.33	-0.37
Short Term Debt	0.0	-0.06	-0.07	0.34	-0.17	0.1	-0.05	-0.08	-0.08	0.34	-0.08	0.1	0.7	0.1		-0.1	-0.05	-0.05	-0.01	-0.09	-0.11	-0.14	-0.13	-0.04
Common Stock	0.85	0.78	0.84	0.1	0.36	-0.97	0.94	0.77	0.95	0.55	0.81	-0.71	0.44	0.65	-0.1		0.36	0.8	0.42	0.9	-0.16	0.82	-0.21	-0.81
Property Plant Equipment	0.52	0.5	0.48	0.47	-0.25	-0.32	0.32	0.14	0.2	-0.08	0.45	-0.46	0.12	0.52	-0.05	0.36		0.48	0.47	0.18	0.73	0.21	0.21	-0.15
Net Invested Capital	0.97	1.0	1.0	0.58	-0.24	-0.79	0.63	0.7	0.65	0.63	0.97	-0.97	0.42	0.94	-0.05	0.8	0.48		0.82	0.46	0.13	0.53	0.25	-0.47
Net Working Capital	0.78	0.84	0.8	0.81	-0.64	-0.42	0.22	0.43	0.23	0.47	0.73	-0.84	0.27	0.94	-0.01	0.42	0.47	0.82		0.03	0.41	0.09	0.48	-0.12
Intangible Assets	0.55	0.44	0.52	-0.27	0.69	-0.84	0.95	0.62	0.92	0.37	0.49	-0.34	0.34	0.29	-0.09	0.9	0.18	0.46	0.03		-0.32	0.84	-0.52	-0.83
Deferred Long Term Liab	0.15	0.16	0.11	0.57	-0.56	0.2	-0.17	-0.16	-0.37	-0.12	0.08	-0.16	-0.03	0.26	-0.11	-0.16	0.73	0.13	0.41	-0.32		-0.22	0.59	0.45
Capital Stock	0.67	0.49	0.56	-0.24	0.52	-0.81	0.8	0.75	0.85	0.31	0.67	-0.37	0.33	0.32	-0.14	0.82	0.21	0.53	0.09	0.84	-0.22		-0.31	-0.79
Short Term Investments	0.16	0.27	0.19	0.66	-0.67	0.12	-0.42	-0.08	-0.36	0.15	0.24	-0.33	0.02	0.33	-0.13	-0.21	0.21	0.25	0.48	-0.52	0.59	-0.31		0.45
Long Term Investments	-0.58	-0.44	-0.51	0.24	-0.53	0.84	-0.73	-0.59	-0.91	-0.19	-0.55	0.34	-0.31	-0.37	-0.04	-0.81	-0.15	-0.47	-0.12	-0.83	0.45	-0.79	0.45

Click cells to compare fundamentals

To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.

Competition

Predict Neuronetics

Based on the company's disclosures, Neuronetics has a Z Score of 0.0. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.

Neuronetics ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Neuronetics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Neuronetics' managers, analysts, and investors.

Environmental

Governance

Social

Neuronetics Institutional Holders

Institutional Holdings refers to the ownership stake in Neuronetics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Neuronetics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Neuronetics' value.

		Shares
Blackrock Inc	2025-03-31	415.9 K
Ghisallo Capital Management Llc	2025-03-31	400 K
Boothbay Fund Management, Llc	2025-03-31	347.2 K
Centerbook Partners Lp	2025-03-31	326.1 K
Geode Capital Management, Llc	2025-03-31	322.8 K
Cubist Systematic Strategies, Llc	2025-03-31	286.6 K
Bank Of America Corp	2025-03-31	253.6 K
Awm Investment Company Inc	2025-03-31	245.9 K
Walleye Trading Advisors, Llc	2025-03-31	242.4 K
Vanguard Group Inc	2025-03-31	2.3 M
Balyasny Asset Management Llc	2025-03-31	1.4 M

Neuronetics Fundamentals

	Return On Equity	-1.44
	Return On Asset	-0.19
	Profit Margin	(0.54) %
	Operating Margin	(0.34) %
	Current Valuation	360.95 M
	Shares Outstanding	66.11 M
	Shares Owned By Insiders	9.48 %
	Shares Owned By Institutions	62.55 %
	Number Of Shares Shorted	4.71 M
	Price To Book	8.43 X
	Price To Sales	3.30 X
	Revenue	74.89 M
	Gross Profit	57.41 M
	EBITDA	(34.56 M)
	Net Income	(43.73 M)
	Cash And Equivalents	73.7 M
	Cash Per Share	2.71 X
	Total Debt	82.63 M
	Debt To Equity	0.63 %
	Current Ratio	4.02 X
	Book Value Per Share	0.54 X
	Cash Flow From Operations	(31 M)
	Short Ratio	4.65 X
	Earnings Per Share	(1.32) X
	Target Price	6.83
	Number Of Employees	716
	Beta	1.85
	Market Capitalization	295.53 M
	Total Asset	140.9 M
	Retained Earnings	(419.79 M)
	Working Capital	26.86 M
	Net Asset	140.9 M

About Neuronetics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Neuronetics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Neuronetics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Neuronetics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet

When determining whether Neuronetics is a strong investment it is important to analyze Neuronetics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neuronetics' future performance. For an informed investment choice regarding Neuronetics Stock, refer to the following important reports:

How To Invest In Neuronetics

Details

Is Neuronetics Stock a good investment?

Details

What is Neuronetics' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Neuronetics Piotroski F Score and Neuronetics Valuation analysis.

To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.

You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuronetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.32)

Revenue Per Share

2.251

Quarterly Revenue Growth

0.836

Return On Assets

(0.19)

Return On Equity

(1.45)

The market value of Neuronetics is measured differently than its book value, which is the value of Neuronetics that is recorded on the company's balance sheet. Investors also form their own opinion of Neuronetics' value that differs from its market value or its book value, called intrinsic value, which is Neuronetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuronetics' market value can be influenced by many factors that don't directly affect Neuronetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

Neuronetics Stock Z Score

Neuronetics Company Z Score Analysis

Z Score

Sum Of

5 Factors

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

Neuronetics Z Score Driver Correlations

Neuronetics ESG Sustainability

Neuronetics Institutional Holders

Neuronetics Fundamentals

About Neuronetics Fundamental Analysis

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY